Journals / Anadolu Kardiyoloji Dergisi / 2013 / Cilt: 13 - Sayı: 7

Long-term prostaglandin E1 use in newborns with duct-dependent congenital heart diseases: one year experience of a tertiary neonatal intensive care unit in Turkey

Duktus-bağımlı konjenital kalp hastalıklı yenidoğanlarda uzun süreli prostaglandin E1 kullanımı: Türkiye’de üçüncü basamak bir yenidoğan yoğun bakım ünitesinin bir yıllık deneyimi

Pages
732–734
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

DİLLİ, D., KOÇ, M., ZENCİROĞLU, A., OKUMUŞ, N., ÜSTÜN, N., ÇINAR, G., ÖZGÜR, S. (2022). Long-term prostaglandin E1 use in newborns with duct-dependent congenital heart diseases: one year experience of a tertiary neonatal intensive care unit in Turkey. Anadolu Kardiyoloji Dergisi, Cilt: 13 - Sayı: 7, 732–734. https://ajindex.com/articles/436227

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Caballero S, Torre I, Arias B, Blanco D, Zabala JI, Sanchez Luna M. Secondary effects of prostaglandin E1 on the management of hypoplastic left heart syndrome while waiting for heart transplantation. An Esp Pediatr 1998; 48: 505-9
  2. Teixeria OH, Carpenter B, McMurray S, Vlad P Long term prostaglandin E1 therapy in congenital heart defects. J Am Coll Cardiol 1984; 3: 838-43. [CrossRef] 3. Kosiak W, Swieton D, Fryze I, Aleszewicz-Baranowska J, Duklas M, Chojnicki M. Gastric outlet obstruction due to an iatrogenic cause in a neonatal period - report of two cases. Ultraschall Med 2009; 30: 401-3. [CrossRef] 4. Talosi G, Katona M, Turi S. Side effects of long term prostaglandin E (1) treatment in neonates. Pediatr Int 2007; 49: 335-40. [CrossRef] 5. Iyú D, Jüttner M, Glenn JR, White AE, Johnson AJ, Fox SC, et al. PGE1 and PGE2 modify platelet function through different prostanoid receptors. Prostaglandins Other Lipid Mediat 2011; 94: 9-16. [CrossRef]